
Keywords: RA; rheumatoid arthritis; RCT; randomized controlled trial; DMARDs; Non-biologic Disease-Modifying Anti-Rheumatic Drugs; HDL; high-density lipoprotein; LDL; low-density lipoprotein; ESR; erythrocyte sedimentation rate; CRP; C-reactive protein; TG; triglyc